ENLV net incomeFY2025$1.24B
ENLV net income was $1.24B for fiscal 2025 (ended Dec 31, 2025), compared with -$15.01M in fiscal 2024. Fiscal 2025 is the highest of the 14 fiscal years on file.
Enlivex Ltd. (ENLV) financials
For fiscal 2025 (ended Dec 31, 2025), Enlivex Ltd. reported $1.24B of net income.
- Net income, FY2025
- $1.24B
- Free cash flow, FY2025
- -$10.48M
- EPS, diluted, FY2025
- $25.48
- Cash
- $1.89M
- P/E
- 0.00
- Market cap
- $1.8M
FY2016FY2025
FY2016FY2025
ENLV revenue and earnings growth
ENLV EPSFY2025$25.48
ENLV diluted EPS was $25.48 for fiscal 2025 (ended Dec 31, 2025).
ENLV free cash flowFY2025-$10.48M
ENLV free cash flow was -$10.48M for fiscal 2025 (ended Dec 31, 2025), compared with -$13.11M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $9.20M | $10.62M | $19.01M | $18.69M | $12.88M | $6.09M | $5.60M | $4.01M | $1.69M | $8.88M |
| Selling, general and admin | $5.80M | $4.91M | $6.14M | $7.10M | $6.41M | $3.70M | $3.02M | $1.29M | $480.0K | $5.90M |
| Operating income | -$15.03M | -$15.89M | -$29.39M | -$25.80M | -$19.29M | -$9.79M | -$8.62M | -$5.30M | -$2.17M | -$15.87M |
| Pre-tax income | $1.62B | -$15.01M | -$29.07M | - | $14.47M | $11.82M | $9.38M | $4.24M | $2.50M | -$15.81M |
| Income tax | $382.65M | - | - | - | - | - | - | -$4.0K | $28.0K | $216.0K |
| Net income | $1.24B | -$15.01M | -$29.07M | -$31.06M | -$14.47M | -$11.82M | -$9.38M | -$4.24M | -$2.50M | -$16.02M |
| EPS, basic | $27.04 | -$0.73 | -$1.56 | -$1.69 | -$0.81 | -$0.90 | -$1.11 | -$1.40 | -$0.94 | -$40.13 |
| EPS, diluted | $25.48 | -$0.73 | -$1.56 | -$1.69 | -$0.81 | -$0.90 | -$1.11 | -$1.40 | -$0.94 | -$40.13 |
| Diluted shares | 48.5M | 20.5M | 18.6M | 18.4M | 17.9M | 13.2M | 8.6M | 3.5M | 3.4M | 399,219 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.89M | $3.30M | $1.23M | $50.36M | $11.64M | $7.01M | $5.52M | $9.79M | $9.03M | $3.04M |
| Short-term investments | - | $198.0K | $5.11M | - | $62.92M | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | $16.0K | $28.0K | $52.0K |
| Current assets | $1.74B | $25.99M | $33.76M | $52.33M | $86.44M | $38.12M | $16.42M | $10.28M | $3.62M | $10.54M |
| Total assets | $2.33B | $27.69M | $36.83M | $67.64M | $95.15M | $40.36M | $17.56M | $11.03M | $3.62M | $10.63M |
| Current liabilities | $9.02M | $3.80M | $6.06M | $6.61M | $4.72M | $4.37M | $5.98M | $1.13M | $460.0K | $1.93M |
| Total liabilities | $392.05M | $4.10M | $6.75M | $10.80M | $10.11M | $4.87M | $6.28M | $1.33M | $1.05M | - |
| Shareholders' equity | $1.93B | $23.59M | $30.08M | $56.84M | $85.04M | $35.49M | $11.28M | $9.71M | $8.49M | $2.81M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.42M | -$13.01M | -$23.52M | -$23.95M | -$17.54M | -$11.01M | -$7.04M | -$3.16M | -$2.30M | -$15.49M |
| Capital expenditures | $68.0K | $103.0K | $236.0K | $8.12M | $1.63M | $1.02M | $193.0K | $461.0K | $130.0K | $18.0K |
| Free cash flow | -$10.48M | -$13.11M | -$23.76M | -$32.08M | -$19.17M | -$12.03M | -$7.23M | -$3.62M | -$2.43M | -$15.50M |
| Investing cash flow | -$1.32M | $9.06M | -$25.97M | $62.52M | -$38.41M | -$20.98M | -$6.36M | -$501.0K | -$130.0K | $8.98M |
| Financing cash flow | $10.38M | $6.45M | $360.0K | $150.0K | $60.98M | $33.08M | $8.31M | $5.19M | $8.05M | $6.09M |
| Stock-based compensation | $1.78M | $2.06M | $1.95M | $2.71M | $2.91M | $670.0K | $810.0K | $1.01M | $121.0K | $700.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | 63.9% | -63.6% | -96.6% | -54.6% | -17.0% | -33.3% | -83.2% | -43.7% | -29.5% | -570.2% |
| Return on assets | 53.1% | -54.2% | -78.9% | -45.9% | -15.2% | -29.3% | -53.4% | -38.4% | -69.1% | -150.7% |
| Current ratio | 193.24 | 6.84 | 5.57 | 7.92 | 18.32 | 8.72 | 2.75 | 9.09 | 7.87 | 5.46 |
Income statement
| Line item | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$3.07M | -$4.58M | -$3.72M | -$4.49M | -$4.83M | -$3.59M | -$3.74M | -$3.32M |
| Net income | -$3.07M | -$4.67M | -$3.69M | -$4.59M | -$4.83M | -$3.55M | -$3.69M | -$3.30M |
| EPS, basic | -$0.19 | -$0.28 | -$0.22 | -$0.32 | -$0.34 | -$0.25 | -$0.26 | -$0.23 |
| EPS, diluted | -$0.19 | -$0.28 | -$0.22 | -$0.32 | -$0.34 | -$0.25 | -$0.26 | -$0.23 |
Balance sheet
| Line item | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.04M | - | - | - | $7.29M | - | - | - |
| Receivables | $52.0K | - | - | - | $145.0K | - | - | - |
| Current assets | $10.54M | - | - | - | $20.39M | - | - | - |
| Total assets | $10.63M | - | - | - | $20.52M | - | - | - |
| Current liabilities | $1.93M | - | - | - | $2.51M | - | - | - |
| Shareholders' equity | $2.81M | - | - | - | $17.93M | - | - | - |
Cash flow
Key ratios
Source: XBRL data Enlivex Ltd. files with the SEC, latest filing dated Mar 25, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
ENLV peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| ENLV | - | - | $1.24B | - | $1.8M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.35T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $675.92B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $519.48B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $364.98B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $311.52B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $289.61B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.31B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $180.22B |
ENLV FAQ
6 questionsIs ENLV profitable?
Yes. Enlivex Ltd. earned $1.24B in net income for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does ENLV have?
Enlivex Ltd. reported $1.89M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is ENLV free cash flow?
Enlivex Ltd. generated -$10.48M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$10.42M less capital expenditures.What is ENLV earnings per share?
Diluted earnings per share were $25.48 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did ENLV last report financial results?
The latest statements here come from Enlivex Ltd.'s 20-F filed on Mar 25, 2026, covering the period ended Dec 31, 2025.Where does this ENLV financial data come from?
Quantisnow builds these statements from the structured XBRL data Enlivex Ltd. files with the SEC. It is provided for information only and is not investment advice.